Cargando…

Optimizing quantification of MK6240 tau PET in unimpaired older adults

Accurate measurement of Alzheimer’s disease (AD) pathology in older adults without significant clinical impairment is critical to assessing intervention strategies aimed at slowing AD-related cognitive decline. The U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (POI...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, Theresa M., Ward, Tyler J., Murphy, Alice, Baker, Suzanne L., Dominguez, Pablo A., Koeppe, Robert, Vemuri, Prashanthi, Lockhart, Samuel N., Jung, Youngkyoo, Harvey, Danielle J., Lovato, Laura, Toga, Arthur W., Masdeu, Joseph, Oh, Hwamee, Gitelman, Darren R., Aggarwal, Neelum, Snyder, Heather M., Baker, Laura D., DeCarli, Charles, Jagust, William J., Landau, Susan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957642/
https://www.ncbi.nlm.nih.gov/pubmed/36455762
http://dx.doi.org/10.1016/j.neuroimage.2022.119761
_version_ 1784894872038146048
author Harrison, Theresa M.
Ward, Tyler J.
Murphy, Alice
Baker, Suzanne L.
Dominguez, Pablo A.
Koeppe, Robert
Vemuri, Prashanthi
Lockhart, Samuel N.
Jung, Youngkyoo
Harvey, Danielle J.
Lovato, Laura
Toga, Arthur W.
Masdeu, Joseph
Oh, Hwamee
Gitelman, Darren R.
Aggarwal, Neelum
Snyder, Heather M.
Baker, Laura D.
DeCarli, Charles
Jagust, William J.
Landau, Susan M.
author_facet Harrison, Theresa M.
Ward, Tyler J.
Murphy, Alice
Baker, Suzanne L.
Dominguez, Pablo A.
Koeppe, Robert
Vemuri, Prashanthi
Lockhart, Samuel N.
Jung, Youngkyoo
Harvey, Danielle J.
Lovato, Laura
Toga, Arthur W.
Masdeu, Joseph
Oh, Hwamee
Gitelman, Darren R.
Aggarwal, Neelum
Snyder, Heather M.
Baker, Laura D.
DeCarli, Charles
Jagust, William J.
Landau, Susan M.
author_sort Harrison, Theresa M.
collection PubMed
description Accurate measurement of Alzheimer’s disease (AD) pathology in older adults without significant clinical impairment is critical to assessing intervention strategies aimed at slowing AD-related cognitive decline. The U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (POINTER) is a 2-year randomized controlled trial to evaluate the effect of multicomponent risk reduction strategies in older adults (60-79 years) who are cognitively unimpaired but at increased risk for cognitive decline/dementia due to factors such as cardiovascular disease and family history. The POINTER Imaging ancillary study is collecting tau-PET ([(18)F]MK6240), beta-amyloid (Aβ)-PET ([(18)F]florbetaben [FBB]) and MRI data to evaluate neuroimaging biomarkers of AD and cerebrovascular pathophysiology in this at-risk sample. Here 481 participants (70.0±5.0; 66% F) with baseline MK6240, FBB and structural MRI scans were included. PET scans were coregistered to the structural MRI which was used to create FreeSurfer-defined reference regions and target regions of interest (ROIs). We also created off-target signal (OTS) ROIs to examine the magnitude and distribution of MK6240 OTS across the brain as well as relationships between OTS and age, sex, and race. OTS was unimodally distributed, highly correlated across OTS ROIs and related to younger age and sex but not race. Aiming to identify an optimal processing approach for MK6240 that would reduce the influence of OTS, we compared our previously validated MRI-guided standard PET processing and 6 alternative approaches. The alternate approaches included combinations of reference region erosion and meningeal OTS masking before spatial smoothing as well as partial volume correction. To compare processing approaches we examined relationships between target ROIs (entorhinal cortex (ERC), hippocampus or a temporal meta-ROI (MetaROI)) SUVR and age, sex, race, Aβ and a general cognitive status measure, the Modified Telephone Interview for Cognitive Status (TICSm). Overall, the processing approaches performed similarly, and none showed a meaningful improvement over standard processing. Across processing approaches we observed previously reported relationships with MK6240 target ROIs including positive associations with age, an Aβ+> Aβ- effect and negative associations with cognition. In sum, we demonstrated that different methods for minimizing effects of OTS, which is highly correlated across the brain within subject, produced no substantive change in our performance metrics. This is likely because OTS contaminates both reference and target regions and this contamination largely cancels out in SUVR data. Caution should be used when efforts to reduce OTS focus on target or reference regions in isolation as this may exacerbate OTS contamination in SUVR data.
format Online
Article
Text
id pubmed-9957642
institution National Center for Biotechnology Information
language English
publishDate 2023
record_format MEDLINE/PubMed
spelling pubmed-99576422023-02-24 Optimizing quantification of MK6240 tau PET in unimpaired older adults Harrison, Theresa M. Ward, Tyler J. Murphy, Alice Baker, Suzanne L. Dominguez, Pablo A. Koeppe, Robert Vemuri, Prashanthi Lockhart, Samuel N. Jung, Youngkyoo Harvey, Danielle J. Lovato, Laura Toga, Arthur W. Masdeu, Joseph Oh, Hwamee Gitelman, Darren R. Aggarwal, Neelum Snyder, Heather M. Baker, Laura D. DeCarli, Charles Jagust, William J. Landau, Susan M. Neuroimage Article Accurate measurement of Alzheimer’s disease (AD) pathology in older adults without significant clinical impairment is critical to assessing intervention strategies aimed at slowing AD-related cognitive decline. The U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (POINTER) is a 2-year randomized controlled trial to evaluate the effect of multicomponent risk reduction strategies in older adults (60-79 years) who are cognitively unimpaired but at increased risk for cognitive decline/dementia due to factors such as cardiovascular disease and family history. The POINTER Imaging ancillary study is collecting tau-PET ([(18)F]MK6240), beta-amyloid (Aβ)-PET ([(18)F]florbetaben [FBB]) and MRI data to evaluate neuroimaging biomarkers of AD and cerebrovascular pathophysiology in this at-risk sample. Here 481 participants (70.0±5.0; 66% F) with baseline MK6240, FBB and structural MRI scans were included. PET scans were coregistered to the structural MRI which was used to create FreeSurfer-defined reference regions and target regions of interest (ROIs). We also created off-target signal (OTS) ROIs to examine the magnitude and distribution of MK6240 OTS across the brain as well as relationships between OTS and age, sex, and race. OTS was unimodally distributed, highly correlated across OTS ROIs and related to younger age and sex but not race. Aiming to identify an optimal processing approach for MK6240 that would reduce the influence of OTS, we compared our previously validated MRI-guided standard PET processing and 6 alternative approaches. The alternate approaches included combinations of reference region erosion and meningeal OTS masking before spatial smoothing as well as partial volume correction. To compare processing approaches we examined relationships between target ROIs (entorhinal cortex (ERC), hippocampus or a temporal meta-ROI (MetaROI)) SUVR and age, sex, race, Aβ and a general cognitive status measure, the Modified Telephone Interview for Cognitive Status (TICSm). Overall, the processing approaches performed similarly, and none showed a meaningful improvement over standard processing. Across processing approaches we observed previously reported relationships with MK6240 target ROIs including positive associations with age, an Aβ+> Aβ- effect and negative associations with cognition. In sum, we demonstrated that different methods for minimizing effects of OTS, which is highly correlated across the brain within subject, produced no substantive change in our performance metrics. This is likely because OTS contaminates both reference and target regions and this contamination largely cancels out in SUVR data. Caution should be used when efforts to reduce OTS focus on target or reference regions in isolation as this may exacerbate OTS contamination in SUVR data. 2023-01 2022-11-28 /pmc/articles/PMC9957642/ /pubmed/36455762 http://dx.doi.org/10.1016/j.neuroimage.2022.119761 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) )
spellingShingle Article
Harrison, Theresa M.
Ward, Tyler J.
Murphy, Alice
Baker, Suzanne L.
Dominguez, Pablo A.
Koeppe, Robert
Vemuri, Prashanthi
Lockhart, Samuel N.
Jung, Youngkyoo
Harvey, Danielle J.
Lovato, Laura
Toga, Arthur W.
Masdeu, Joseph
Oh, Hwamee
Gitelman, Darren R.
Aggarwal, Neelum
Snyder, Heather M.
Baker, Laura D.
DeCarli, Charles
Jagust, William J.
Landau, Susan M.
Optimizing quantification of MK6240 tau PET in unimpaired older adults
title Optimizing quantification of MK6240 tau PET in unimpaired older adults
title_full Optimizing quantification of MK6240 tau PET in unimpaired older adults
title_fullStr Optimizing quantification of MK6240 tau PET in unimpaired older adults
title_full_unstemmed Optimizing quantification of MK6240 tau PET in unimpaired older adults
title_short Optimizing quantification of MK6240 tau PET in unimpaired older adults
title_sort optimizing quantification of mk6240 tau pet in unimpaired older adults
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957642/
https://www.ncbi.nlm.nih.gov/pubmed/36455762
http://dx.doi.org/10.1016/j.neuroimage.2022.119761
work_keys_str_mv AT harrisontheresam optimizingquantificationofmk6240taupetinunimpairedolderadults
AT wardtylerj optimizingquantificationofmk6240taupetinunimpairedolderadults
AT murphyalice optimizingquantificationofmk6240taupetinunimpairedolderadults
AT bakersuzannel optimizingquantificationofmk6240taupetinunimpairedolderadults
AT dominguezpabloa optimizingquantificationofmk6240taupetinunimpairedolderadults
AT koepperobert optimizingquantificationofmk6240taupetinunimpairedolderadults
AT vemuriprashanthi optimizingquantificationofmk6240taupetinunimpairedolderadults
AT lockhartsamueln optimizingquantificationofmk6240taupetinunimpairedolderadults
AT jungyoungkyoo optimizingquantificationofmk6240taupetinunimpairedolderadults
AT harveydaniellej optimizingquantificationofmk6240taupetinunimpairedolderadults
AT lovatolaura optimizingquantificationofmk6240taupetinunimpairedolderadults
AT togaarthurw optimizingquantificationofmk6240taupetinunimpairedolderadults
AT masdeujoseph optimizingquantificationofmk6240taupetinunimpairedolderadults
AT ohhwamee optimizingquantificationofmk6240taupetinunimpairedolderadults
AT gitelmandarrenr optimizingquantificationofmk6240taupetinunimpairedolderadults
AT aggarwalneelum optimizingquantificationofmk6240taupetinunimpairedolderadults
AT snyderheatherm optimizingquantificationofmk6240taupetinunimpairedolderadults
AT bakerlaurad optimizingquantificationofmk6240taupetinunimpairedolderadults
AT decarlicharles optimizingquantificationofmk6240taupetinunimpairedolderadults
AT jagustwilliamj optimizingquantificationofmk6240taupetinunimpairedolderadults
AT landaususanm optimizingquantificationofmk6240taupetinunimpairedolderadults